LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis. - Wikidata - wikimedia - TriplyDB

LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis.

LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis.

http://www.wikidata.org/entity/Q35242466

about

PD-1/CTLA-4 Blockade Inhibits Epstein-Barr Virus-Induced Lymphoma Growth in a Cord Blood Humanized-Mouse Model Animal models of tumorigenic herpesviruses--an update Epstein-Barr virus ensures B cell survival by uniquely modulating apoptosis at early and late times after infection Hypoxia-inducible factor-1α plays roles in Epstein-Barr virus's natural life cycle and tumorigenesis by inducing lytic infection through direct binding to the immediate-early BZLF1 gene promoter.Novel roles and therapeutic targets of Epstein-Barr virus-encoded latent membrane protein 1-induced oncogenesis in nasopharyngeal carcinoma.Epstein-Barr virus latency: current and future perspectives.An essential EBV latent antigen 3C binds Bcl6 for targeted degradation and cell proliferation.Manipulation of the host cell membrane by human γ-herpesviruses EBV and KSHV for pathogenesis.Recent advances in understanding Epstein-Barr virus.Lytic EBV infection investigated by detection of Soluble Epstein-Barr virus ZEBRA in the serum of patients with PTLD.Epstein-Barr Virus LMP1 Mediated Oncogenicity.Adoptively transferred Vγ9Vδ2 T cells show potent antitumor effects in a preclinical B cell lymphomagenesis model.Leflunomide/teriflunomide inhibit Epstein-Barr virus (EBV)- induced lymphoproliferative disease and lytic viral replication.Latent Membrane Protein 1 (LMP1) and LMP2A Collaborate To Promote Epstein-Barr Virus-Induced B Cell Lymphomas in a Cord Blood-Humanized Mouse Model but Are Not Essential.Characterization of a Suppressive Cis-acting Element in the Epstein-Barr Virus LMP1 Promoter.c-Myc Represses Transcription of the Epstein-Barr Virus Latent Membrane Protein 1 Early After Primary B Cell Infection.Current Progress in EBV-Associated B-Cell Lymphomas.Modeling Human Antitumor Responses In Vivo Using Umbilical Cord Blood-Engrafted Mice.EBV persistence without its EBNA3A and 3C oncogenes in vivo.Human γ-Herpesvirus Infection, Tumorigenesis, and Immune Control in Mice with Reconstituted Human Immune System Components.An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model Co-Expression of the Epstein-Barr Virus-Encoded Latent Membrane Proteins and the Pathogenesis of Classic Hodgkin Lymphoma

P2860

Q27313748-C90E2630-F905-43A3-AE48-E0E770CC41B7 Q28083747-E2A5B20A-3253-4F89-BE7D-2E2ACF921CD5 Q33658144-2976B50C-1471-4DFF-B7B1-DCF1DFBE113B Q33842381-306DD050-C595-4A7B-80F0-4FFE351613B6 Q38568602-B4DF48C8-0CE0-4647-850A-B90949F85838 Q38603533-2521D92C-12C6-4805-845A-28876E9B4DAE Q38664787-EB13DD64-A1F3-43A9-B5E9-BD029179743E Q38953504-851D4D75-3576-4C62-81C5-6F5634B735BD Q39241944-4D203DA5-1A6E-4396-82C8-0E379EFC537B Q40056807-79D2FB72-ED36-4947-B60A-0857CA3E65F3 Q40073030-8F4F026E-7A93-4F7F-8886-D269392823D7 Q40146526-259C34FD-5435-45FD-8FFA-214FD27B1931 Q40175806-A07D5330-1EBF-4B4A-914E-2A4D0CC68231 Q40375799-CAF43843-BCF3-4F6D-BE9D-BCE6256AC60D Q45323690-C651DE3E-5BBD-4066-82B1-B4198769B4E5 Q45325105-DE74FD05-BF6B-43A0-86D6-1811A057AA48 Q47606345-1E410112-8E65-46FC-A096-2909BC216F81 Q50054545-635354A6-6B93-4B4C-BDD7-8BA37BBDCBC0 Q52803943-CD2F4C6F-3ABA-4B74-BEB7-DCB5F56A41CB Q54266087-465E6EB9-BD71-44ED-A0D4-37B995A7F1A1 Q57025486-29E52218-44C0-41E8-AE01-7F91C083DF21 Q58704308-E70D0F95-707E-4CAB-8F14-7056F04E7751

P2860

LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis.

http://www.wikidata.org/entity/Q35242466

description

2014 nî lūn-bûn

@nan

2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis.

@ast

LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis.

@en

type

label

LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis.

@ast

LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis.

@en

prefLabel

LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis.

@ast

LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis.

@en

P1433

Q35242466-4CA024AF-BD07-4F7D-86E5-2DF9D44657BD

P1476

Q35242466-DE47DAF8-5373-48A3-B7D4-89FDF7333B5C

P2093

Q35242466-00CFBE13-EC2E-4826-BADB-63E7AF23BD20

Q35242466-244D5238-0A92-4C9C-AA20-EB8F26356FAA

Q35242466-4CA146D0-5385-4FF3-8BF1-12A7D4D39390

Q35242466-7039D315-6DFC-44BD-9A66-37AFC4AAAE68

Q35242466-79875429-E970-4CFF-AC73-0641F0015BE9

Q35242466-7D7AF24A-7620-4C93-87EE-81D0D772681C

Q35242466-A7E2A72B-6722-4D08-A1A6-F954F55A48DE

Q35242466-CB118480-CB31-41FB-BB83-D0143781FA06

Q35242466-D570EB67-B38E-4394-9000-AFF114B6C496

Q35242466-D8A9A909-CDBF-44B2-A219-E3001DE28D40

P2860

Q35242466-1468F049-ADA7-4B07-A692-4FF9A9070656

Q35242466-1634D774-BDB3-4DA8-86A5-4AFD944D517D

Q35242466-1CBFA0A0-FE32-4089-AFDF-4CD33B0C9F86

Q35242466-1FDF57B7-6CA8-4F9B-BAEE-A5777966BF71

Q35242466-2D43FB53-D819-4A46-88A3-0BF86733B8E0

Q35242466-31FB652E-EA4D-47A6-83DD-0F4FCF021D61

Q35242466-32394DEE-DC61-4969-97A0-8F2D6D474EBF

Q35242466-328C5719-EB9E-4A8F-8C53-B9873CBDB1FC

Q35242466-37C92794-2414-43BE-B69B-C7F82F43AC3A

Q35242466-386A7F46-1FD4-4EE1-AD22-5FEDE8C39F50

P304

Q35242466-294A3451-714A-47E9-B769-C6876CA6078A

P31

Q35242466-02595708-A71F-4B91-9B40-187604D4D3CE

P356

Q35242466-52B6361C-6CC5-4128-983B-162FFF8009EA

P407

Q35242466-10BE300F-CD4F-45CD-8EEA-0316153618E2

P433

Q35242466-1057050D-9338-4CA3-AE9B-4866F76D1E48

P478

Q35242466-816DE589-76CE-4760-A551-300771EDEFAF

P577

Q35242466-B4780F8B-501C-46D4-ADB2-7968CFB42F8C

P698

Q35242466-99AE999A-DF54-4697-9890-7A336EE78E18

P921

Q35242466-EA6D3ADE-14CF-45CE-A2E9-9EAEB5FABC7E

P932

Q35242466-8D0B3F18-F475-4496-9412-0852F637E717

P356

P1433

Journal of Clinical Investigation

P1476

LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis.

@en

P2093

Erik A Ranheim

http://www.w3.org/2001/XMLSchema#string

Ethel Cesarman

http://www.w3.org/2001/XMLSchema#string

Fotis Asimakopoulos

http://www.w3.org/2001/XMLSchema#string

Jeffrey L Jensen

http://www.w3.org/2001/XMLSchema#string

Jenny E Gumperz

http://www.w3.org/2001/XMLSchema#string

Julie Plowshay

http://www.w3.org/2001/XMLSchema#string

Margaret L Gulley

http://www.w3.org/2001/XMLSchema#string

Shannon C Kenney

http://www.w3.org/2001/XMLSchema#string

Shi-Dong Ma

http://www.w3.org/2001/XMLSchema#string

Weihua Tang

http://www.w3.org/2001/XMLSchema#string

P2860

Oncogenic IRFs provide a survival advantage for Epstein-Barr virus- or human T-cell leukemia virus type 1-transformed cells through induction of BIC expression

Priming of protective T cell responses against virus-induced tumors in mice with human immune system components

Exploiting synthetic lethality for the therapy of ABC diffuse large B cell lymphoma

A novel monoclonal antibody to CD40 prolongs islet allograft survival

EBV latent membrane protein 1 activates Akt, NFkappaB, and Stat3 in B cell lymphomas.

Induction of p16(INK4a) is the major barrier to proliferation when Epstein-Barr virus (EBV) transforms primary B cells into lymphoblastoid cell lines.

Human BLyS facilitates engraftment of human PBL derived B cells in immunodeficient mice.

CD34+ cord blood cell-transplanted Rag2-/- gamma(c)-/- mice as a model for Epstein-Barr virus infection

CD40 ligand (CD154) incorporated into HIV virions induces activation-induced cytidine deaminase (AID) expression in human B lymphocytes.

Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor

P304

304-315

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI76357

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

125

http://www.w3.org/2001/XMLSchema#string

P577

2014-12-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25485679

http://www.w3.org/2001/XMLSchema#string

P921

Epstein–Barr virus

P932

4382240

http://www.w3.org/2001/XMLSchema#string